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It is generally accepted that tolerance to thymus-dependent antigens affects 
both T  and B cells. It has been shown that thymocytes as well as T  cells in the 
spleen become tolerant to, e.g., human gammaglobulin  (HGG)  ~ in less than  1 
day  (1).  Also,  splenic  B  cells were rapidly tolerized to HGG, the time period 
being less than I  day (1) or varying from 2 to 4 days (2). Thus, there appears to 
be no major differences between splenic T  and B  cells with regard to tolerance 
induction, but there is a pronounced difference with regard to the kinetics of the 
spontaneous loss of tolerance, which occurs in less than 60 days in B  cells, but 
requires more than 100 days in T  cells (2). 
It has been shown that the polyclonal B-cell activator lipopolysaccharide (LPS) can 
interfere with induction of tolerance (3) and is able to change an otherwise tolerogenic 
stimulus  into an immunogenic one  (4-6).  LPS also has the  ability to make haptens 
immunogenic (7). These effects of LPS do not appear to require participation ofT cells and 
are likely to represent a direct effect of LPS on B cells (2, 5). 
Polyclonal B-cell activators  (PBA) are ligands  which directly activate B  cells into 
division and polyclonal immunoglobin secretion without participation of helper cells, 
such as T cells and macrophages (8). It has been suggested that the triggering signal 
given by PBA in pelyclonal activation is the same as that responsible for induction of 
specific antibody synthesis after injection of thymus-independent antigens (9) and, conse- 
quently, that the immunogtobin receptors do not deliver any triggering signals to B cells 
(9,  10). It follows from this  concept that the  immunoglobin receptors also cannot be 
responsible for the signal  delivery in induction of paralysis.  Since thymus-dependent 
(TD) antigens lack the inbuilt triggering property of thymus-independent (TI) antigens 
(11), TD antigens cannot directly activate B cells. Therefore, tolerance to a TD antigen 
cannot exist at the B-cell level, if tolerance is defined as a change from the resting state to 
a  tolerant state as a  consequence of a  signal.  A formal proof for the existence of an 
induced state of tolerant B cells (or the absence of immunecompetent B cells) would be to 
activate B cells from tolerant animals by PBA and fail to detect induction of antibodies 
* This work was supported by grants from the Swedish Cancer Society and the Swedish Medical 
Research Council. 
1  Abbreviations used in this paper: BSS, balanced salt solution; FITC, fluorescein isothiocya- 
hate; HGG, human gamma globulin; LPS, lipopolysaccharide; PBA, polyclonal B-cell activators; 
PFC, plaque-forming cells; TD, thymus-dependent;  TI, thymus-independent. 
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against  the tolerogen.  Only one such  study  has been performed  as yet  (12)  and  it was 
indeed found that cells from animals tolerized by injections of free hapten were activated 
by PBA to antihapten  antibody synthesis. 
In the  present  paper  it was  studied whether  tolerance  induced  against  a  TD 
hapten-protein  complex  results  in deletion  or inactivation  of the specific B  cells, 
or whether  PBA  activation  could reveal  normal  numbers  of immunocompetent 
B  cells  in  tolerant  animals.  It  was  found  that  TD  antigens  could  not  induce 
tolerance  in the  B-cell compartment. 
Materials and Methods 
Mice.  FI hybrids between the inbred strains A and B10.5M were used in experiments. 
Mitogens.  LPS from Escherichia coli  O55:B5,  obtained from Dr.  T.  Holme,  Department  of 
Bacteriology, Karolinska  Institute,  Stockholm,  Sweden,  was prepared  by phenol-water extrac- 
tion. 
Preparation of Lymphocytes.  Spleens were removed and teased with forceps in ice-cold bal- 
anced salt solution (BSS). After brief sedimentation, the cells in the supernates were washed three 
times in 50 ml of cold BSS and subsequently  suspended  in culture medium to the desired cell 
concentration. Cellular and viability counts were performed in hemocytometers after staining the 
damaged cells with 0.02% trypan blue. 
Medium.  The  medium  used  in  most  of the  experiments  was  Eagle's  minimum  essential 
medium in Earle's solution, supplemented with glutamine, nonessential amino acids, and pyru- 
vate and containing 100 IU of penicillin and 100 tzg of streptomycin/ml, as described by Mishell 
and Dutton (13). The medium was further buffered by 10 mM of HEPES and the pH adjusted to 
7.0-7.2.  All these reagents were obtained from Flow Laboratories, Irvine, Scotland. All experi- 
ments were carried out in serum-free medium (14). 
Culture Conditions.  Induction of antibody synthesis was always performed in 3-cm diameter 
plastic Petri dishes  (Nunc,  Denmark),  with a  cell concentration  of 107 spleen cells/ml in  1 ml 
cultures, set up in triplicate. Cultures were incubated at 37°C in plastic boxes filled with a mixture 
of 10% CO2, 83% N2, and 7% 02 and were rocked on a platform at 8 oscillations/min. 
Assay of  Antibody Synthesis.  A modified (15) hemolytic plaque assay (16) was used to quanti- 
tate  cellular antibody  production  in  culture.  Cells were harvested  with  a  plastic  spatula  and 
washed twice in cold BSS and adjusted to the desired cell concentration. 0.6 ml of 0.5% agar (Bacto 
Agar; Difco Laboratories,  Detroit,  Mich.) in  BSS containing 0.05%  DEAE-dextran  (Pharmacia 
Fine Chemicals, Inc., Uppeala, Sweden) was added to 3-ml plastic tubes, which were kept at 46°C 
in a water bath. Thereafter, 0.05 ml of the indicator erythrocytes diluted 1:8 in BSS, 0.2 ml of the 
lymphocyte cell suspension, and 0.05 ml of guinea pig serum diluted 1:4 in BSS were added to each 
tube. The ingredients were mixed and the mixture was evenly spread on plastic Petri dishes with 
9-cm diameters, which were thereafter incubated for 3 h at 37°C. Plaque-forming cells (PFC) were 
counted, using indirect light. Sheep erythrocytes haptenated with different concentrations of the 
fluorescein isothiocyanate (FITC) hapten were used as indicators in the assay. The sheep erythro- 
cytes, always obtained from the same donor, were stored in sterile Alsever's solution and washed 
twice in  BSS before haptenation.  Washed  sheep  erythrocytes  were suspended  in a  carbonate- 
bicarbonate buffer, pH 9.2 (20%, vol/vol), and kept with permanent stirring at room temperature. 
FITC was then added to the erythrocytes and the mixture incubated for 40 min at room tempera- 
ture. The haptenated erythrocytes were finally washed extensively in BSS and used in the plaque 
assay. A concentration of 0.5 mg/ml of FITC during conjugation was used to detect high affinity 
and of 5 mg/ml to detect low affinity anti-FITC PFC. 
Conjugation of  FITC to Various Carriers.  FITC (Isomer 1; BDH Chemicals, Poole, England) 
was conjugated to proteins according to the method of Bergquist and Schilling (17). In short, FITC 
was dissolved in bicarbonate buffer, pH 9.23.  The FITC concentration was 10 mg/ml. 3.3 ml of the 
FITC solution were enclosed in dialysis bags. The bags were immersed in 10-ml HGG solutions 
containing 10 mg protein/ml. The proteins used were previously dissolved in the same bicarbonate 
buffer, pH 9.23.  The mixture was stirred for 24 h  at 0°C and thereafter the protein solution was 
added to a Sephadex G-25 column and eluted with a phosphate buffer, pH 7. The protein solution 
was filtered until sterile and made up to a  protein concentration of 2.5 mg/mt. M~LLER  ET  AL.  1431 
LPS could not be efficiently labeled by the above procedure, and therefore the following method 
was adopted (18).  10 mg/m] of LPS were dissolved in bicarbonate buffer, pH 9.2, and in a separate 
vessel 2 mg/ml of FITC was dissolved in the same buffer. To 1 ml LPS solution was added 3 ml of 
the FITC solution. The mixture was stirred overnight and LPS separated from nov_reacted FITC by 
passage through Sephadex G-25 column. The FITC content per mole of protein or LPS was kindly 
determined  spectrophotometrically by Dr.  R.  Bergquist,  National  Bacteriological  Laboratory, 
Stockholm, Sweden, according to the method of McKinney et al.  (19).  The HGG preparation was 
FITCIo-HGG and the LPS solution was FITC~o-LPS. In the latter case a  tool wt of LPS of 108 was 
assumed (4/~g FITC/mg LPS). 
Preparation of Aggregated FITC-HGG.  The FITCIo-HGG described above was either used in 
soluble form or precipitated with 9% alum adjusted to pH 6.5.  The precipitate was extensively 
washed, the pH adjusted to 7.2, and it was finally resuspended in BSS at a concentration of 2 rag/ 
ml.  It was  injected at  a  dose  of 400  ftg/mouse together with  109 Bordetella pertussis  bacteria 
intraperitoneally. 
Preparation of Deaggregated F1TC-HGG.  The  procedure  of  Chiller  and  Weigle  (20)  was 
followed.  Thus,  FITC~o-HGG was centrifuged for 2 h  at 150,000 g  and thereafter the upper one- 
third of the material was removed and immediately injected intravenously in a  dose of 2.5 rag/ 
mouse in a  total vol of 0.1 ml. 
Experimental Procedure.  (A ×  5M)F~ mice (eight mice per experiment) were injected with 2.5 
rag deaggregated HGG at day 0, followed by a second injection given between 1 and 5 days after the 
first. After an additional 1-11 days the spleens were removed from three mice and added in culture 
together with LPS or in some experiments with FITC-LPS.  The PFC response against FITC was 
determined  2  or  4  days  later.  The  five  remaining tolerogen-treated  animals,  as  well  as  five 
previously untreated mice, were immunized with precipitated FITC-HGG plus B. pertussis bacte- 
ria. This immunization was repeated and 5 to 10 days later the spleen of the animals were tested 
for PFC against FITC.  In addition, the cells from each individual mouse were added in culture 
together with LPS and the anti-FITC PFC response determined 2 days later. 
This experimental protocol makes it possible to reveal the existence of resting immunocompe- 
tent anti-FITC cells in animals within 4-11 days after tolerance induction as well as in animals 
which in addition have been immunized twice and thereafter tested 13-19 days after tolerance 
induction. The immunization also constitutes the control for successful tolerance induction. 
Results 
Spleen  Cells from  Tolerant Animals  are  Activated  by LPS  to  Synthesize 
Antibodies against the Tolerogen.  As can be seen in Table I and Fig. 1, spleen 
cells taken 4-11  days after injection of a total of 5 mg FITC-HGG given in two 
injections and put in culture for 2 days did not develop spontaneous anti-FITC 
PFC and were in this respect comparable to untreated controls. However, when 
given an optimal polyclonal concentration of  LPS (100 ~g/ml) cells from tolerant 
animals exhibited a  marked increased number of both high and low affinity 
anti-FITC PFC, which reached the same level as in previously untreated ani- 
mals when the time period between the last tolerizing dose and the removal of 
the spleen was 6 days, whereas there was a somewhat suppressed response when 
the interval was short  (1  day).  However,  also in this case there was a  very 
pronounced increase of the number of anti-FITC PFC  response,  being about 
fivefold of the background. 
It was also tested whether these spleen cells were specifically tolerant to FITC 
by trying to induce a specific immune response against the thymus-independent 
antigen FITClo-LPS. As shown in Fig.  2,  FITCIo-LPS caused an immune re- 
sponse in spleen cells from untreated animals, whereas there was no response 
with cells from tolerant animals, indicating that these cells were indeed tolerant 
to FITC,  even when attempts were made to stimulate a  specific immune re- 
sponse by FITC coupled to a thymus-independent carrier. 1432  ABSENCE  OF  B-CELL  TOLERANCE 
TABLE I 
In Vitro Induction of Anti-FITC PFC by LPS in Spleen  Cells from Animals Injected 
Twice with Deaggregated FITC-ttGG* 
Anti-FITC PFC/ 
Treatment of  mice  In culture  106  cells 
Exp. no. 
High  Low af- 
With  At days  Day  With  affinity  finity 
-  -  2  11 
-  LPS  124  197 
DA$ FITC-HGG  0 and 5  11  -  6  15 
DA FITC-HGG  0 and 5  11  LPS  68  190 
-  -  11  26 
-  LPS  234  429 
DA FITC-HGG  0 and 4  5  -  13  28 
DA FITC-HGG  0 and 4  5  LPS  60  123 
* Spleen  cells  from animals  treated  as  described  in  the Materials and  Methods were  cultivated  in 
vitro  with  or  without  100  ~g  LPS  for  2  days.  Thereafter,  three  cultures  per  group  were  pooled  and 
assayed  for  the number of  anti-FITC PFC. 
DA, deaggregated. 
Immunization  of  Tolerant  Animals  does  not  Change  the  Response  to 
LPS.  In order to verify the tolerant state of the animals at the time when their 
cells could be activated by LPS to produce specific anti-FITC PFC, the animals 
were immunized twice with precipitated FITC-HGG together with B. pertussis 
bacteria. The animals were tested 8-14 days after immunization for direct and, 
in some experiments,  indirect PFC  against  FITC.  In addition,  the cells were 
added in culture in the presence or absence of LPS. As shown in Table II, the 
tolerant animals failed to mount a  specific anti-FITC response after immuniza- 
tion and usually contained the same or lower numbers of PFC as compared to 
completely unimmunized mice.  In contrast,  immunized animals exhibited the 
expected high  number  of both  direct  and  indirect  PFC.  Thus  the  telerogen- 
treated animals remained tolerant after immunization. 
However, when the same cells were activated by LPS in vitro they developed 
high numbers  of specific anti-FITC  PFC,  the numbers being equal  or nearly 
equal to those found in previously untreated animals stimulated by LPS (Table 
III). The longer the interval between the last FITC-HGG injection and addition 
to  culture,  the  smaller  was  the  difference between  untreated  and  tolerant 
animals. Thus, spleen cells from tolerant animals could be activated by LPS into 
synthesis of antibodies against the tolerogen. 
Discussion 
In these studies tolerance to FITC-HGG was induced by conventional proce- 
dures  and  the tolerant  animals  or cells from these  animals  failed to become 
immunized against  a  TD and a  TI immunogen.  The experimental system was 
selected  because  it  is  well  analyzed  and  appears  to  represent  a  "classical" 
tolerance situation without involvement of suppressor T  cells (2). 
Since  polyclonal  concentrations  of LPS  always  induced  the  formation  of MOLLER  ET  AL.  1433 
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antibodies  against  the tolerogen it must be concluded that  specific B  cells in 
tolerant animals are present in normal numbers. Thus, tolerance cannot be due 
to a process leading to elimination or functional inactivation of specific B cells. 
Since these B cells failed to become specifically activated by TI (FITC-LPS) or 
TD (FITC-HGG) antigens, the most likely explanation of the findings is that the 
Ig receptors were incapable of binding the antigenic determinants. 
We suggest that the most simple explanation of the presence of B cells that b
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can be activated by PBA but not by antigen, is that the Ig receptors are blocked 
by  the  tolerogen.  This  has  not  been  directly  studied  in  these  or  previous 
experiments,  but  the  findings  of Aldo-Benson  and  Borel  (21)  have  clearly 
demonstrated  antigen  on  B  cells from tolerant  animals.  A  number  of other 
findings  are  also compatible  with  this  possibility.  Thus,  tolerance  to certain 
haptens (22) and to LPS (23) is rapidly broken if the cells are cultured in vitro in 
the absence of the tolerogen or by simply washing the cells before addition to the 
cultures.  It has also been observed (24) that DNP-D-Gly,Lys which is a  potent 
tolerogen,  actually binds to about 3% of the spleen cells in vitro and remains 
attached to the cell surface during in vitro cultivation. 
The findings that tolerance to TD antigens could be broken by the injection of 
cross-reacting  antigens  was  already  earlier  explained  on  the  basis  that  the 
tolerant animals possessed responsive B cells but lacked specific immunocompe- 
tent T  cells (25).  The present findings go one step further by postulating that 
there is always a normal complement of B cells in tolerant animals irrespective 
of the time after tolerance induction and thus,  that there exists no true B-cell 
tolerance to TD antigens.  However, it does not necessarily follow from this that 
it should be possible to break tolerance by the injection of cross-reacting anti- 
gens  at  any  time  period  after  tolerance  induction,  since  the  reason  for  the 
inability to trigger these cells with a hapten TI carrier is presumably that the Ig 
receptors are blocked by antigen.  In such a  case it is not to be expected that 
injection of cross-reacting antigen,  causing activation of new T cells, would be 
competent to break tolerance,  since the responding B cells have their receptor 
occupied by  antigen.  It  is  not  known  how  long  the  receptor blockade  could 
persist, but the finding that tolerance can be broken by cross-reacting antigen 
suggests  that  it  does  not  persist  for  very long  time  periods.  Therefore,  the 
spontaneous appearance of immune responsiveness as determined by, e.g.  cell 
reconstitution experiments or injection of cross-reacting antigens may in fact be 
a measure of the time it takes to clear the Ig receptors from antigen, rather than 
the time necessary for the reappearance of antigen-reactive  B cells. 
It was observed that when the interval between the tolerogenic or immuno- 
genic challenge and the addition of cells from the treated animals to culture was 
short,  there  was  a  less  than  normal  LPS-induced  response  to  the  hapten, 
whereas there was a  normal response when the interval was longer (11 days). 
This  cannot  have been due to partial  tolerance  at the  B-cell level,  since the 
animals were completely tolerant, both when attempts were made to immunize 
them in vivo and in vitro with the hapten or a TI carrier.  Most likely this is due 
to  some  trivial  effects,  possibly  caused  by the  fact  that  the  antigen  is  an 
immunoglobulin  as  pointed  out  before  (2)  or  else  caused  by  a  phenomenon 
analogous  to  effector  cell  blockade  (26),  in  which  antigen  bound  to  the  Ig 
receptor cause some disturbance of the cell, which is expressed as an inability to 
secrete antibodies.  Whatever the mechanism,  the small suppression  observed 
here with cells from tolerant animals is most likely due to a nonspecific effect on 
the cell surface not relevant for the triggering process. 
Our findings show that the only stringent test for the presence of tolerant B 
cells in tolerant  animals  is the failure  of PBA to activate antibody synthesis 
against the tolerogen. This test has now been used in two different test systems M~LLER  ET  AL.  1437 
and in both cases were immunocompetent B cells found in tolerant animals (12). 
Analogous  studies  have  not  as  yet  been  performed  by  others.  It  must  be 
concluded that TD antigens cannot induce tolerance in B  cells, but only in T 
cells.  This is in accordance with the postulates of the one nonspecific signal 
hypothesis (8,  9),  but is incompatible with a  two signal hypothesis, which is 
based on signal discrimination for the induction of tolerance and immunity. 
Another consequence of the one nonspecific signal concept as well as from the 
present findings, is that immunocompetent B  cells towards TD autoantigens 
should normally exist. However, they cannot normally be activated into anti- 
body synthesis, because there are no helper T cells available. 
Summary 
Immunological tolerance was induced in adult mice by the injection of 5 mg of 
deaggregated hapten-protein conjugate. The tolerant state was confirmed 4-19 
days later by the failure of such animals to mount an immune response against 
an aggregated form of the same thymus-dependent hapten-protein conjugate as 
well as by the inability of spleen cells from tolerant animals to respond to a 
thymus-independent hapten-carrier conjugate. Even though the animals were 
fully tolerant, their spleen cells were activated by lipopolysaccharide (LPS) in 
vitro to produce normal numbers of plaque-forming cells against the hapten. 
The finding that spleen cells from tolerant animals could be activated by LPS 
into synthesis of antibodies against the tolerogen indicates that tolerance to 
thymus-dependent antigens does not affect B cells, but presumably only T cells. 
It is suggested that the only stringent test for the existence of B-cell tolerance is 
the  inability  of polyclonal  B-cell  activators  to  activate  antibody  synthesis 
against the tolerogen. The findings make it unlikely that B-cell tolerance to 
autologous thymus-dependent antigens exists  and further indicate that such 
antigens cannot deliver activating or tolerogenic signals to B  cells,  although 
they are competent to combine with and block the Ig receptors. 
The technical assistance of Miss Inger Cederberg and Miss Yrsa Avellan is gratefully acknowl- 
edged. 
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